Latest On Mitsubishi Tanabe Pharma Corporation (MTZXF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-11-26 22:58 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-08 02:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-19 01:25 EST | News | Zosano Pharma teams up with Mitsubishi Tanabe Pharma on patch-administered drug | N/A | |
| 2020-08-14 11:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 14:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 22:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-30 06:09 EST | Dividend | A dividend of $28 has been announced on May 10, 2019. It will be paid Jan 1, 1970 with an ex-dividend date of Mar 30, 2020. | Neutral | |
| 2020-03-25 22:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 06:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 00:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 01:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 01:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-10 15:37 EST | Earnings | Earnings have been released on September 30, 2017, with $0.21 earnings per share. | Sell | |
| 2020-02-10 15:37 EST | Earnings | Earnings have been released on June 30, 2017, with $0.27 earnings per share. | Buy | |
| 2020-02-10 15:37 EST | Earnings | Earnings have been released on September 30, 2016, with $0.25 earnings per share. | Buy | |
| 2020-02-10 15:37 EST | Earnings Estimate | An EPS average of $0.75 is estimated for the 2020 year. | Buy | |
| 2020-02-10 15:37 EST | Earnings | Earnings have been released on March 31, 2018, with $0.10 earnings per share. | Sell | |
| 2020-02-10 15:37 EST | Earnings | Earnings have been released on December 31, 2017, with $0.35 earnings per share. | Sell | |
About Mitsubishi Tanabe Pharma Corporation (MTZXF):
Mitsubishi Tanabe Pharma Corporation manufactures and sells pharmaceuticals in Japan, Europe, North America, other Asian countries, and internationally. The company primarily offers drugs for immuno-inflammation, diabetes and kidney, and central nervous system diseases; vaccines; and OTC products. It offers Simponi, a treatment agent for rheumatoid arthritis (RA); Canalia, Invokana, Tenelia, and Canaglu, treatment agents for type 2 diabetes mellitus; Stelara and Amiselimod for treatment of Crohn's disease; Radicava, an amyotrophic lateral sclerosis (ALS) treatment agent; Gilenya, a treatment agent for multiple sclerosis; and Remicade for treatment of RA, Crohn's disease, and various inflammatory autoimmune diseases. The company also provides Lexapro, an anti-depressant agent; Imusera for multiple sclerosis; Rupafin, an oral allergy treatment agent; Talion, an anti-allergic agent; Fasinumab, a human anti-NGF monoclonal antibody; Dersimelagon for immnuno-inflammation; Vadadustat, for treatment of renal anemia; and Apararenone, for treatment of non-alcoholic steatohepatitis. In addition, it offers vaccines, such as influenza vaccine, Tetrabik, Mearubik, Varicella vaccine, and JEBIK V. The company has collaborations with Dyadic International, Inc.; Hitachi Ltd.; HitGen Ltd.; and Viela Bio, Inc. The company was founded in 1678 and is headquartered in Osaka, Japan. Mitsubishi Tanabe Pharma Corporation is a subsidiary of Mitsubishi Chemical Holdings Corporation.
General
- Name Mitsubishi Tanabe Pharma Corporation
- Symbol MTZXF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorOther
- IndustryOther
- Full Time Employees 7,228
- Fiscal Year EndMarch
- Web URLhttp://www.mt-pharma.co.jp
Valuation
- Trailing PE 79.6
- Forward PE 204.08
- Price/Sales (Trailing 12 Mt.) 2.88
- Price/Book (Most Recent Quarter) 1.28
- Enterprise Value Revenue 0.02
- Enterprise Value EBITDA 0.21
Financials
- Most Recent Quarter 0000-00-00
- Revenue Per Share $0
- Gross Profit 244.12 billion
- Quarterly Earnings Growth 0%
ESG Rating
Highlights
- Market Capitalization 10.15 billion
- PEG Ratio -43116.6
Share Statistics
- % Held by Insiders <1%
Technicals
- 50 Day Moving Average 18.08
- 200 Day Moving Average 15.1
Dividends
- Dividend Date 2018-06-25
- ExDividend Date N/A
- Dividend Per Share $0.51
Mitsubishi Tanabe Pharma Corporation (MTZXF) Dividend Calendar:
MTZXF's last dividend payment was made to shareholders on June 25, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|---|---|---|---|
| 2019-09-27 | 2019-12-02 | 2019-09-30 | 2019-05-10 | $28 |
| 2019-03-29 | 2019-06-24 | 2019-03-31 | 2018-05-09 | $28 |
| 2018-09-28 | 2018-12-03 | 2018-09-30 | 2018-05-09 | $28 |
| 2018-03-29 | 2018-06-25 | 2018-03-31 | 2017-05-10 | $28 |
| 2017-03-30 | 2017-06-22 | 2017-03-31 | 2016-05-11 | $28 |
| 2016-09-29 | 2016-12-01 | 2016-09-30 | 2016-05-11 | $24 |
| 2016-03-30 | 2016-06-23 | 2016-03-31 | 2015-05-08 | $24 |
| 2020-03-30 | 0000-00-00 | 2020-03-31 | 2019-05-10 | $28 |
| 2020-03-30 | 2020-03-31 | 2019-05-10 | $28 |
Mitsubishi Tanabe Pharma Corporation (MTZXF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2018-12-31 | 2018-12-31 | $1.12 billion | $0.26 | ||
| 2018-09-30 | 2018-09-30 | $916.03 million | $0.18 | ||
| 2018-06-30 | 2018-06-30 | $950.01 million | $0.23 | ||
| 2018-03-31 | 2018-03-31 | $892.79 million | $0.10 | $0.17 | -43.29% |
| 2017-12-31 | 2017-12-31 | $1.12 billion | $0.35 | $0.37 | -4.89% |
| 2017-09-30 | 2017-09-30 | $936.89 million | $0.21 | $0.26 | -20.62% |
| 2017-06-30 | 2017-06-30 | $958.43 million | $0.27 | $0.25 | 8.96% |
| 2017-03-31 | 2017-03-31 | $894.34 million | $0.17 | ||
| 2016-12-31 | 2016-12-31 | $120.24 billion | $0.39 | ||
| 2016-09-30 | 2016-09-30 | $0.25 | $0.23 | 9% | |
| 2016-06-30 | 2016-06-30 | $0.36 | |||
| 2016-03-31 | 2016-03-31 | -$0.06 | |||
| 2015-12-31 | 2015-12-31 | $0.45 | |||
| 2015-09-30 | 2015-09-30 | $0.21 | |||
| 2015-06-30 | 2015-06-30 | $0.22 | |||
| 2015-03-31 | 2015-03-31 | -$0.13 | |||
| 2014-12-31 | 2014-12-31 | $0.25 | |||
| 2014-09-30 | 2014-09-30 | $0.39 | |||
| 2014-06-30 | 2014-06-30 | $0.17 | |||
| 2014-03-31 | 2014-03-31 | $0.03 | |||
| 2013-12-31 | 2013-12-31 | $0.27 | |||
| 2013-09-30 | 2013-09-30 | $0.33 | |||
| 2013-06-30 | 2013-06-30 | $0.19 | |||
| 2013-03-31 | 2013-03-31 | $0.13 | |||
| 2012-12-31 | 2012-12-31 | $0.35 | |||
| 2012-09-30 | 2012-09-30 | $0.20 | |||
| 2012-06-30 | 2012-06-30 | $0.24 | |||
| 2012-03-31 | 2012-03-31 | $0.07 | |||
| 2011-12-31 | 2011-12-31 | $0.37 | |||
| 2011-09-30 | 2011-09-30 | $0.20 | |||
| 2011-06-30 | 2011-06-30 | $0.25 | |||
| 2011-03-31 | 2011-03-31 | -$0.03 | |||
| 2010-12-31 | 2010-12-31 | $0.36 | |||
| 2010-09-30 | 2010-09-30 | $0.17 | |||
| 2010-06-30 | 2010-06-30 | $0.28 | |||
| 2010-03-31 | 2010-03-31 | -$0.05 | |||
| 2009-12-31 | 2009-12-31 | $0.38 | |||
| 2009-09-30 | 2009-09-30 | $0.04 | |||
| 2009-06-30 | 2009-06-30 | $0.21 |
Mitsubishi Tanabe Pharma Corporation (MTZXF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Mitsubishi Tanabe Pharma Corporation (MTZXF) Chart:
Mitsubishi Tanabe Pharma Corporation (MTZXF) News:
Below you will find a list of latest news for Mitsubishi Tanabe Pharma Corporation (MTZXF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Mitsubishi Tanabe Pharma Corporation (MTZXF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Mitsubishi Tanabe Pharma Corporation (MTZXF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|